Understanding Phenergan's Side Effect Profile
Common Side Effects of Promethazine
The most frequently reported side effects of Phenergan relate to its antihistamine and anticholinergic properties. Drowsiness occurs in approximately 70-80% of patients, which can be beneficial when treating insomnia but may interfere with daytime activities. Dry mouth affects around 30% of users due to reduced saliva production. Other common effects include blurred vision, constipation, and dizziness, particularly when standing up quickly. These effects are generally dose-dependent and tend to diminish as the body adapts to treatment.
Serious Side Effects Requiring Medical Attention
Whilst rare, certain side effects require immediate medical assessment. Respiratory depression, characterised by slow or shallow breathing, can occur particularly in elderly patients or when combined with other sedating medications. Severe allergic reactions, though uncommon with antihistamines, may manifest as facial swelling, difficulty breathing, or widespread rash. Extrapyramidal symptoms, including involuntary muscle movements or tremor, can develop with prolonged use. Any signs of jaundice, persistent nausea, or confusion should prompt immediate medical review.
Age-Related Considerations and Vulnerable Groups
Elderly patients demonstrate increased sensitivity to Promethazine's anticholinergic effects, with higher risks of confusion, falls, and urinary retention. Children under two years face particular risks of respiratory depression and should not receive Promethazine. Pregnant women should use Promethazine only when benefits clearly outweigh risks, particularly during the third trimester. Patients with cardiovascular conditions, prostatic enlargement, or narrow-angle glaucoma require careful monitoring due to anticholinergic effects.
Drug Interactions and Safety Considerations
Promethazine's sedating effects can be significantly amplified when combined with alcohol, opioids, benzodiazepines, or other CNS depressants. This combination increases risks of severe sedation and respiratory depression. Monoamine oxidase inhibitors (MAOIs) can intensify anticholinergic effects and should be used together only under specialist supervision. Patients taking medications for Parkinson's disease may experience reduced therapeutic effects due to Promethazine's dopamine-blocking properties.
Available Formulations at EverydayMeds
EverydayMeds stocks both Phenergan 25mg tablets and Phenergan Elixir 5mg/5ml oral solution to accommodate different patient needs and preferences. The tablet formulation provides precise dosing for adult patients, whilst the elixir allows for flexible dosing adjustments and easier administration for those with swallowing difficulties. Both formulations contain the same active ingredient, Promethazine hydrochloride, ensuring consistent therapeutic effects across different presentations.
